NIH Guide to Grants and Contracts

The NIH Guide for Grants and Contracts is our official publication for NIH grant policies, guidelines and funding opportunities. We publish daily, and issue a table of contents weekly. Learn more about the NIH Guide and subscribe today!

The old advanced search is still avaliable.

New Features:

  • Tabular view - You can now view the search results in table format.
  • Export to excel - Search results can now be exported to excel for reporting purposes.

Results: 1 to 25 of 42

Display Results as:

Title FOA Number Organization Released Expires Activity Code
Tobacco Regulatory Science (R01 Clinical Trial Optional)  RFA-OD-19-028  ODP  09-25-2019  02-14-2021  R01 
Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)  RFA-HL-20-006  NHLBI  09-09-2019  01-15-2022  K38 
Stimulating Access to Research in Residency (StARR) (R38)  RFA-HL-18-023  NHLBI  08-23-2017  05-13-2020  R38 
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)  RFA-OD-19-022  ODP  07-08-2019  03-09-2021  R21 
Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed)  RFA-CA-19-051  NCI  09-06-2019  06-24-2021  U54 
Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed)  RFA-CA-19-050  NCI  09-05-2019  06-24-2021  U01 
Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed)  RFA-CA-19-049  NCI  09-05-2019  06-24-2021  R01 
Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed)  RFA-CA-19-053  NCI  09-05-2019  06-24-2021  P50 
Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed)  RFA-CA-19-052  NCI  09-05-2019  06-24-2021  P01 
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)  RFA-CA-20-023  NCI  12-20-2019  09-30-2020  U54 
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)  RFA-CA-20-026  NCI  12-20-2019  09-30-2020  U2C 
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)  RFA-CA-20-021  NCI  12-20-2019  09-30-2020  R01 
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)  RFA-CA-20-025  NCI  12-20-2019  09-30-2020  P50 
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)  RFA-CA-20-024  NCI  12-20-2019  09-30-2020  P01 
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)  RFA-CA-20-022  NCI  12-20-2019  09-30-2020  U01 
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)  RFA-CA-20-005  NCI  01-16-2020  11-18-2020  R21 
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)  RFA-CA-20-004  NCI  01-16-2020  11-18-2020  R01 
Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed)  RFA-CA-20-032  NCI  01-10-2020  03-20-2020  R01 
Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)  RFA-CA-19-032  NCI  01-24-2019  08-04-2020  R01 
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional)  RFA-CA-19-045  NCI  07-30-2019  07-31-2020  U2C 
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)  RFA-CA-19-046  NCI  07-30-2019  07-31-2020  U24 
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required)  RFA-CA-20-015  NCI  11-19-2019  02-27-2020  K99/R00 
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Not Allowed)  RFA-CA-20-014  NCI  11-19-2019  02-27-2020  K99/R00 
Methods and Measurement in Research with Sexual and Gender Minority (SGM) Populations (R21- Clinical Trials Not Allowed)  RFA-MD-20-005  NIMHD  12-23-2019  03-14-2020  R21 
Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed)  RFA-OD-19-021  ODP  07-08-2019  03-09-2021  R21 

Current Search

Clear All Filters

Organization(s): NCI

Refine Your Results

Program Announcements (PAs)

Parent Announcments Only

Requests for Applications (RFAs)

Issuing Only

All Organizations

AHRQ

CDC

CSR

DHHS

DOJ

EPA

FDA

FIC

HRSA

NASA

NCATS

NCBDDD

NCCDPHP

NCCIH

NCEH

NCHSTP

NCI

NCID

NCIPC

NCMHD

NCPHI

NCRR

NEI

NHGRI

NHLBI

NIA

NIAAA

NIAID

NIAMS

NIBIB

NICHD

NIDA

NIDCD

NIDCR

NIDDK

NIEHS

NIGMS

NIH

NIMH

NIMHD

NINDS

NINR

NIOSH

NIP

NLM

OAR

OBSSR

OD

ODP

ODS

OPHR

OPPNET

ORD

ORI

ORIP

ORWH

OSC

RMOD

Roadmap

SAMHSA

*On or After
*On or After
(e.g. "K" for K01 or K02, K05, etc.)
Back to Top